HQL
Tekla Life Sciences Investors
17.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1.1% | 4.6% | 4.8% | 0.1% | 2.3% | 1.3% | 0.0% | 0.0% | 0.2% | 1.3% | 0.1% | 0.2% | |
| 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.3% | -1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 0.0% | 0.0% | 2.4% | 0.1% | 0.0% | 0.3% | 1.0% | 0.0% | 0.0% | 3.8% | 0.0% | 0.0% | |
| 0.1% | 0.3% | 2.4% | 0.0% | 2.3% | 1.1% | 0.0% | 0.0% | 0.2% | 1.3% | 0.1% | 0.2% | |
| 0.0% | 0.0% | – | 2.2% | 0.0% | 4.5% | – | 3.2% | 8.1% | 5.0% | – | – | |
| 0.2% | 1.1% | 0.6% | 0.4% | 0.6% | 0.7% | 0.1% | 2.0% | 4.1% | 0.2% | 0.2% | 0.3% | |
| 0.2% | 1.1% | 0.6% | 0.3% | 0.5% | 0.7% | 0.1% | 2.0% | 1.2% | – | 0.2% | 0.1% | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.9% | 2.7% | – | – | – | |
| 0.0% | 0.9% | 0.5% | 0.3% | 0.5% | 0.7% | – | 0.0% | 1.2% | – | 0.0% | 0.1% | |
| 99.8% | 98.9% | 99.4% | 99.6% | 99.4% | 99.1% | 99.9% | 98.0% | 95.9% | 99.8% | 99.8% | 99.7% | |
| 40.7% | 38.8% | -0.7% | 0.0% | 29.6% | 9.9% | 26.2% | 28.2% | 2.3% | -0.4% | 9.6% | 15.1% | |
| 4.3% | 4.2% | 5.0% | 4.6% | 4.7% | 6.0% | 4.9% | 4.5% | 6.2% | 7.0% | 6.1% | 5.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.